Not recruiting
Renal transplant
Not recruitingStudy on the Safety and Effectiveness of Regtivex and Tocilizumab in Patients Receiving HLA-Mismatched Living Donor Kidney Transplants
Registered drugNo placebo
Study on the Safety and Effectiveness of Regtivex and Tocilizumab in Patients Receiving HLA-Mismatched Living Donor Kidney Transplants
Registered drugNo placebo
- Disease:Renal transplant
- Substances:RegtivexTocilizumab
Countries:
Austria
Austria- Participants:18–64 years · 65+ years
- Substances:Regtivex
